NSC highlights 10 cutting-edge technologies aimed at reducing musculoskeletal disorders, with MākuSafe named winner of the ...

MSD has secured approval from the US Food and Drug Administration (FDA) for its subcutaneous (SC) formulation of best-selling cancer asset, Keytruda (pembrolizumab). This makes pembrolizumab and ...

The center terminated Kevin Struthers, who worked at the arts institution for 30 years, and Malka Lasky, the last member of its social impact team. The Kennedy Center has fired the administrator ...

Zweli Bashman, the Managing Director of MSD for South Africa and the sub-Saharan Africa region, a global healthcare leader working to help the world be well, speaks with LARA ADEJORO on its ...

Lorenzo Prieto is a journalism fellow at The Daily Signal. Send an email to Lorenzo. Fox News is shaking up its weekend lineup. Fox News Media President and Executive Editor Jay Wallace announced that ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

Two pharma companies developing lipid-lowering drugs, MSD and Ionis, have reported positive phase 3 data that open the way for regulatory filings in the coming months. First up, MSD, which chalked up ...

Astoria’s KMUN, a local community radio station, is restructuring its broadcast programming after federal cuts erased 20% of the station’s budget. “We lost our Corporation for Public Broadcasting ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Computer programming is the bedrock of the computer systems, ...

MONEY TO GIVE ELIGIBLE, LOW-INCOME FAMILIES A BREAK ON THEIR RATES. "I HAVE NOTICED QUITE AN INCREASE IN THE LAST YEAR. AND WITH EVERYTHING GOING ON IN THE WORLD AND PRICES JUST OVERALL INCREASING, IT ...

US pharmaceutical giant Merck is scrapping a planned £1bn expansion of its UK operations, saying the government is not investing enough in the sector. The multi-national business, known as MSD in ...